CD14 and graft versus host disease: Moreover, given that these immunosuppressive drugs mitigate GvHD by themselves, we can speculate that their combination with CD14+HuMoSC supernatant would also diminish GvHD severity but more in vivo experiments are required to confirm this hypothesis.